Clinical trial
A Phase I Open Label Pilot Study to Evaluate the Safety, Efficacy and Tolerability of Anginera for Adults With Left Ventricular Dysfunction AND Reversible Myocardial Ischemia Undergoing CABG Surgery
NCT00364390 is registered in ClinicalTrials.gov with Theregen, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Open Label Pilot Study to Evaluate the Safety, Efficacy and Tolerability of Anginera for Adults With Left Ventricular Dysfunction AND Reversible Myocardial Ischemia Undergoing CABG Surgery
- Lead sponsor
- Theregen, Inc.
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- April 30, 2006
- Completion date
- February 28, 2009
- Enrollment
- 12 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.